Latest Trials Latest NewsFAQ

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: Tetrathiomolybdate

First Posted Date: 2005-09-19

Last Posted Date: 2024-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT00195091

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer
Erectile Dysfunction

Interventions: Drug: sildenafil citrate and questionaires
Drug: placebo tablets and questionaires

First Posted Date: 2005-09-02

Last Posted Date: 2017-10-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 290

Registration Number: NCT00142506

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States

and more 2 locations

Acupuncture for Post-Thoracotomy Pain

Phase 3

Completed

Conditions: Lung Cancer
Pain

Interventions: Procedure: Acupuncture and Questionnaires
Procedure: Placebo Acupuncture, Questionnaires

First Posted Date: 2005-09-02

Last Posted Date: 2009-01-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 162

Registration Number: NCT00142532

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Effect of Affective Content on Drug Induced Amnesia of Episodic Memory

Phase 1

Completed

Conditions: Memory Losses
Amnesia-Memory Loss

Interventions: Drug: Propofol
Drug: Thiopental Sodium
Drug: Dexmedetomidine Hydrochloride
Drug: Midazolam Hydrochloride
Drug: placebo

First Posted Date: 2005-09-02

Last Posted Date: 2015-12-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 79

Registration Number: NCT00142493

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain

Phase 2

Completed

Conditions: Pain

Interventions: Drug: Methadone
Drug: methadone and morphine

First Posted Date: 2005-09-02

Last Posted Date: 2019-03-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT00142519

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

Phase 3

Completed

Conditions: Sarcoma, Soft Tissue

First Posted Date: 2005-09-02

Last Posted Date: 2007-10-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT00142571

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery

Phase 3

Completed

Conditions: Large Bowel Obstruction

First Posted Date: 2005-09-01

Last Posted Date: 2007-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 180

Registration Number: NCT00140868

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Phase 3

Completed

Conditions: Streptococcal Sepsis
Hematologic Malignancies

First Posted Date: 2005-08-30

Last Posted Date: 2006-09-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 126

Registration Number: NCT00138112

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Psychostimulants for Fatigue in Prostate Cancer

Phase 2

Completed

Conditions: Fatigue
Prostate Cancer

First Posted Date: 2005-08-30

Last Posted Date: 2007-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT00138138

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Acupuncture For Pancreatic Cancer Pain

Phase 3

Completed

Conditions: Pancreatic Neoplasms
Pain

First Posted Date: 2005-08-29

Last Posted Date: 2006-09-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT00136669

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy